Concepedia

Thomas Schaeffer

TS

23

Publications

1.3K

Citations

18

H-Index

1972

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

GlaxoSmithKline (United Kingdom)

GlaxoSmithKline (United States)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Thomas Schaeffer is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1972–2024

23

Publications

23

Dual Metalloprotease Inhibitors:  Mercaptoacetyl-Based Fused Heterocyclic Dipeptide Mimetics as Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase

Jeffrey A. Robl, Chong‐Qing Sun, Jay Stevenson et al. · Journal of Medicinal Chemistry · 1997 · 198 citations · Full text

, , +17

Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme.

Robert J. Laffan, M.E. Goldberg, John P. High et al. · Journal of Pharmacology and Experimental Therapeutics · 1978 · 173 citations

Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic Peptides

Sean Engel, Thomas Schaeffer, Barry Gold et al. · Experimental Biology and Medicine · 1972 · 146 citations

, , +16

Comorbidity in patients with cancer: Prevalence and severity measured by cumulative illness rating scale

Ulrich Wedding, Bernd Roehrig, Almuth Klippstein et al. · Critical Reviews in Oncology/Hematology · 2007 · 96 citations

, , +8

Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.

N. C. Trippodo, Jeffrey A. Robl, Magdi M. Asaad et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 84 citations

Rows per page

1–5 of 23